https://www.raps.org/news-and-articles/news-articles/2018/9/generic-drugmakers-embrace-inter-partes-review-pro
Thanks to Congress@ administrative alternative to court litigation of patents, generic drug manufacturers have embraced a new process, known as inter partes...
inter partes reviewgenericembraceprocessraps